We are live on !
Find out more
Abbrea Capital Portfolio holdings
AUM
$755M
Turnover
11.55%
1-Year Est. Return
24.68%
This Fund
S&P 500
This Quarter Est. Return
+7.26%
1 Year Est. Return
+24.68%
3 Year Est. Return
+38.01%
5 Year Est. Return
+100.94%
10 Year Est. Return
–
AUM
$470M
AUM Growth
+$38.2M
(+8.8%)
Cap. Flow
+$8.56M
Cap. Flow % of AUM
Cap. Flow %
1.82%
Top 10 Holdings %
Top 10 Hldgs %
32.34%
Holding
193
New
12
Increased
67
Reduced
70
Closed
3
Avg Time Held
2.3
years
Top 10 Avg Time Held
2.1
years
Top 20 Avg Time Held
2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$3.38M |
| 2 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$2.5M |
| 3 |
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
|
+$2.26M |
| 4 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$1.57M |
| 5 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$532K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard High Dividend Yield ETF
VYM
|
+$1.23M |
| 2 |
Schwab U.S Small- Cap ETF
SCHA
|
+$468K |
| 3 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$428K |
| 4 |
iShares Core S&P Small-Cap ETF
IJR
|
+$411K |
| 5 |
Apple
AAPL
|
+$320K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 43.03% |
| 2 | Technology | 11.88% |
| 3 | Financials | 8.65% |
| 4 | Consumer Staples | 7.62% |
| 5 | Healthcare | 7.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
26
SPDR Gold Trust
GLD
$141B
| $4.67M | 0.99% |
32,660
+2,135
| +7% | +$298K |
2016 Q4
12 quarters
|
|
|
27
iShares Core S&P Small-Cap ETF
IJR
$102B
| $4.63M | 0.99% |
55,248
-5,105
| -8% | -$411K |
2016 Q4
12 quarters
|
|
28
RTX Corp
RTX
$261B
| $4.6M | 0.98% |
48,828
-406
| -0.8% | -$36.8K |
2016 Q4
12 quarters
|
|
29
Vanguard S&P 500 ETF
VOO
$1.03T
| $4.6M | 0.98% |
15,547
-882
| -5% | -$249K |
2017 Q2
10 quarters
|
|
30
Honeywell
HON
$67B
| $4.57M | 0.97% |
27,394
-121
| -0.4% | -$19.8K |
2016 Q4
12 quarters
|
|
31
Alphabet (Google) Class C
GOOG
$4.12T
| $4.21M | 0.9% |
62,960
-540
| -0.9% | -$34.8K |
2016 Q4
12 quarters
|
|
32
3M
MMM
$85B
| $4.12M | 0.88% |
27,917
-490
| -2% | -$68.6K |
2016 Q4
12 quarters
|
|
33
Merck
MRK
$360B
| $4.09M | 0.87% |
46,842
-553
| -1% | -$45.4K |
2016 Q4
12 quarters
|
|
34
Nike
NKE
$55.1B
| $4.09M | 0.87% |
40,300
+20
| +0% | +$1.88K |
2016 Q4
12 quarters
|
|
35
Berkshire Hathaway Class B
BRK.B
$1.14T
| $3.93M | 0.84% |
17,354
+554
| +3% | +$120K |
2016 Q4
12 quarters
|
|
36
Cisco
CSCO
$423B
| $3.9M | 0.83% |
81,335
-5,640
| -6% | -$262K |
2016 Q4
12 quarters
|
|
37
State Street SPDR MSCI ACWI ex-US ETF
CWI
$2.84B
| $3.78M | 0.81% |
146,882
-500
| -0.3% | -$12.5K |
2016 Q4
12 quarters
|
|
38
NextEra Energy
NEE
$166B
| $3.72M | 0.79% |
61,440
-840
| -1% | -$49K |
2016 Q4
12 quarters
|
|
39
PIMCO 1-5 Year US TIPS Index Exchange-Traded Fund
STPZ
$556M
| $3.59M | 0.76% |
68,349
| – | – |
2016 Q4
12 quarters
|
|
40
Oracle
ORCL
$389B
| $3.58M | 0.76% |
67,546
-498
| -0.7% | -$27.4K |
2016 Q4
12 quarters
|
|
41
Pfizer
PFE
$169B
| $2.94M | 0.63% |
79,208
-2,619
| -3% | -$93.3K |
2016 Q4
12 quarters
|
|
42
Abbott
ABT
$181B
| $2.76M | 0.59% |
31,756
-495
| -2% | -$41.5K |
2016 Q4
12 quarters
|
|
43
Invesco QQQ Trust
QQQ
$475B
| $2.75M | 0.58% |
12,930
| – | – |
2016 Q4
12 quarters
|
|
44
Colgate-Palmolive
CL
$75B
| $2.68M | 0.57% |
38,984
-354
| -0.9% | -$24.1K |
2016 Q4
12 quarters
|
|
45
AbbVie
ABBV
$504B
| $2.61M | 0.55% |
29,444
-850
| -3% | -$70.6K |
2016 Q4
12 quarters
|
|
46
Bank of America
BAC
$358B
| $2.53M | 0.54% |
71,791
+2,120
| +3% | +$68.5K |
2016 Q4
12 quarters
|
|
47
Wells Fargo
WFC
$252B
| $2.51M | 0.53% |
46,573
+662
| +1% | +$34.7K |
2016 Q4
12 quarters
|
|
48
Home Depot
HD
$309B
| $2.47M | 0.53% |
11,309
-94
| -0.8% | -$21.3K |
2016 Q4
12 quarters
|
|
49
FedEx
FDX
$69.5B
| $2.44M | 0.52% |
16,042
-1,424
| -8% | -$219K |
2016 Q4
12 quarters
|
|
50
Verizon
VZ
$186B
| $2.44M | 0.52% |
39,690
-489
| -1% | -$29.5K |
2016 Q4
12 quarters
|
|
Similar funds
PRC
GIM
MCM
Abbrea Capital's Q4 2019 Portfolio in Review
As of Q4 2019, Abbrea Capital held 193 positions worth $470M, up 8.8% from $432M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Abbrea Capital's Q4 2019 filing shows 12 new, 67 increased, 70 reduced and 3 closed positions. Its largest new stake was Bristol-Myers Squibb: 6,099 shares worth $392K. The largest sale was Vanguard High Dividend Yield ETF, an estimated $1.23M.
By sector, the portfolio is most concentrated in Miscellaneous at 43% of assets, up from 43% a quarter earlier, followed by Technology and Financials.
- Abbrea Capital's largest Q4 2019 buy was Bristol-Myers Squibb: 6,099 shares worth $392K.
- Abbrea Capital added most to Vanguard FTSE Developed Markets ETF in Q4 2019, an estimated $3.38M increase.
- Abbrea Capital's biggest Q4 2019 reduction was Vanguard High Dividend Yield ETF, cutting an estimated $1.23M.
- Abbrea Capital fully exited Constellation Brands in Q4 2019, selling an estimated $217K.
- Abbrea Capital's ten largest holdings make up 32% of its $470M portfolio in Q4 2019.
- Abbrea Capital opened 12 new positions and closed 3 in Q4 2019.
- Abbrea Capital's portfolio value rose 8.8% quarter-over-quarter to $470M.
Based on Abbrea Capital's 13F filing for Q4 2019, filed 11 Feb 2020.